Visikol

Visikol is a contract research services company that is focused on accelerating the drug discovery and development process through providing its clients with advanced tissue imaging and advanced cell culture services. Today, Visikol counts all twenty of the top twenty pharmaceutical companies as clients and has been instrumental in dozens of drug discovery programs. The company provides end-to-end services that include 3D tissue imaging, multiplex tissue imaging, digital pathology, high content imaging, 2D cell culture assays, 3D cell culture assays and ex vivo tissue slice assays. Visikols expertise lies in both transforming tissues into actionable insights as well as bridging...

Drug discovery,high throughput screening,high content screening,whole mount imaging,3d cell cultures,in vitro assays,confocal microscopy,antibody penetration,organoids,and digital pathology

Visikol operates in the Biotechnology research industry.

Visikol's revenue is 11m - 100m

Visikol has 11 - 50 employees.